12390 EL CAMINO REAL, SAN DIEGO, CA
Market cap: $9.5B (2/08/2026)
Price: $80.48
Raises 2025 Revenue Estimates, Raises 2026 and Multi-Year Financial Guidance
Performance-Based PSU Grant for CEO Dr. Helen Torley Approved
James Lang Elected to Board of Directors at Halozyme Therapeutics
CFO Transition Plan Announced for Nicole LaBrosse at Halozyme
Halozyme Therapeutics Completes $1.5 Billion Convertible Notes Offering
Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
Announces Proposed Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032
Financial Results, Changes in Board, Management or Compensation
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
Tender Offer Statement by Third Party
Tender Offer Statement by Issuer
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence
Amended Tender Offer Statement by Third Party